Home » Topics » BioWorld Science

BioWorld Science
RSS

Skin microbiome study gives insights into wound healing

April 23, 2019

Enrollment ongoing in phase II study of p53MVA in combination with pembrolizumab

April 18, 2019

Promising phase II data announced for novel allogeneic cell therapy, FCR-001

April 18, 2019

COBRA molecule MVC-101 targets CD3, EGFR for antitumor activity

April 18, 2019

First-in-human study of F-520 recruiting participants

April 18, 2019

Yale scientists restore function in pig brains post-mortem

April 18, 2019

Antitumor compound SRX-3207 inhibits both tyrosine-protein kinase SYK and PI3K

April 18, 2019

Celgene initiates phase I/II study of CC-90011 in extensive-stage small-cell lung cancer

April 18, 2019

Phase Ia data presented for hepatitis B candidate ABI-H2158

April 18, 2019

PureTech and Boehringer to develop immune-oncology candidates using lymphatic targeting platform

April 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...